Skip to content
October 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Treatment Innovations
  • Medical Research and Clinical Trials
  • Genomics and Precision Medicine
  • Survivorship and Post-Treatment
  • Integrative Oncology and Holistic Care
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Breast Cancer Legislation and Policy
  • Breast Cancer Surgery and Reconstruction
Breaking News
market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research the-forgotten-plane-of-motion-how-banana-pose-can-transform-your-spinal-health The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health

Main News

market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
the-forgotten-plane-of-motion-how-banana-pose-can-transform-your-spinal-health
  • Integrative Oncology and Holistic Care

The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health

Nana Muazin October 2, 2026
  • Recommended
  • Popular
  • Archive
  • Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
    • Chemotherapy and Targeted Therapy

    Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

    Basiran October 2, 2026
  • Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
    • Breast Cancer Legislation and Policy

    Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

    Basiran October 2, 2026
  • Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
    • Patient Advocacy and Support

    Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

    Nana October 2, 2026
  • Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
    • Metastatic Breast Cancer Research

    Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

    Evan Lee Salim October 2, 2026
  • Decoding Inflammation: How Real Food Can Empower Breast Cancer Patients and Survivors decoding-inflammation-how-real-food-can-empower-breast-cancer-patients-and-survivors
    • Patient Advocacy and Support

    Decoding Inflammation: How Real Food Can Empower Breast Cancer Patients and Survivors

    Siti Muinah October 2, 2026
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
    • Chemotherapy and Targeted Therapy

    Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

    Basiran October 2, 2026
  • Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
    • Breast Cancer Legislation and Policy

    Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

    Basiran October 2, 2026
  • Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
    • Patient Advocacy and Support

    Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

    Nana October 2, 2026
  • Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
    • Metastatic Breast Cancer Research

    Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

    Evan Lee Salim October 2, 2026

Featured News

market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026

General

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026

Opinion

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026

More

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
In a dramatic market reaction that wiped approximately $1 billion from its valuation, uniQure N.V. faced a...
Read More Read more about Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm
Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
As the calendar turns toward the final quarter of the year, millions of Americans are preparing for...
Read More Read more about Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know
Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
Introduction: A Critical Turning Point for Metastatic Breast Cancer Advocacy In a decisive move to dismantle the...
Read More Read more about Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act
Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
In a decisive move to safeguard the integrity of the nation’s scientific pipeline, the patient advocacy organization...
Read More Read more about Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research
The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health the-forgotten-plane-of-motion-how-banana-pose-can-transform-your-spinal-health
  • Integrative Oncology and Holistic Care

The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health

Nana Muazin October 2, 2026
By Editorial Staff | Published October 2, 2026 In our modern, device-centric world, the human body is...
Read More Read more about The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health
The Green Revolution Beneath Our Feet: How Perennial Grasses Are Reshaping Industrial Chemistry the-green-revolution-beneath-our-feet-how-perennial-grasses-are-reshaping-industrial-chemistry
  • Genomics and Precision Medicine

The Green Revolution Beneath Our Feet: How Perennial Grasses Are Reshaping Industrial Chemistry

Neng Nana October 2, 2026
In an era defined by the urgent need to decouple economic growth from carbon emissions, the industrial...
Read More Read more about The Green Revolution Beneath Our Feet: How Perennial Grasses Are Reshaping Industrial Chemistry
Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Reprograms Cancer’s Defenses mount-sinai-scientists-unveil-trojan-horse-immunotherapy-that-reprograms-cancers-defenses
  • Medical Research and Clinical Trials

Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Reprograms Cancer’s Defenses

Asro October 2, 2026
New Approach Targets Tumor’s Protective Cells, Not Just Cancer Itself, Offering Hope for Metastatic Solid Tumors New...
Read More Read more about Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Reprograms Cancer’s Defenses
Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier navigating-the-future-of-pharma-aaps-pharmsci-360-to-address-the-crisis-of-credibility-and-the-post-animal-frontier
  • Treatment Innovations

Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier

Asep Darmawan October 2, 2026
As the pharmaceutical industry stands at a critical juncture defined by rapid technological acceleration and a growing...
Read More Read more about Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier
Shaping the Future of Prevention: Breast Cancer Canada Applauds New Federal Advisory Committee shaping-the-future-of-prevention-breast-cancer-canada-applauds-new-federal-advisory-committee
  • Psychosocial Support and Mental Health

Shaping the Future of Prevention: Breast Cancer Canada Applauds New Federal Advisory Committee

Raul Delapena Setiawan October 2, 2026
By Editorial Staff In a significant move toward modernizing the nation’s approach to public wellness, the Government...
Read More Read more about Shaping the Future of Prevention: Breast Cancer Canada Applauds New Federal Advisory Committee
The Vanguard of Aesthetic and Reconstructive Care: ASPS and MedTech Innovator Unveil the 2026 Startup Cohort the-vanguard-of-aesthetic-and-reconstructive-care-asps-and-medtech-innovator-unveil-the-2026-startup-cohort
  • Breast Cancer Surgery and Reconstruction

The Vanguard of Aesthetic and Reconstructive Care: ASPS and MedTech Innovator Unveil the 2026 Startup Cohort

Lina Irawan October 2, 2026
In a landscape where precision meets technology, the intersection of plastic surgery and digital health is undergoing...
Read More Read more about The Vanguard of Aesthetic and Reconstructive Care: ASPS and MedTech Innovator Unveil the 2026 Startup Cohort

Posts pagination

1 2 3 4 … 659 Next

Recent Posts

  • Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm
  • Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know
  • Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act
  • Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research
  • The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.